Doctors Note Logo

Published on: 2/10/2026

Vraylar Over 65: Navigating Mental Health in Seniors

For adults over 65, Vraylar (cariprazine) can treat schizophrenia, bipolar I episodes, and serve as add-on therapy for major depressive disorder—but it requires cautious use in older adults. Key considerations include a boxed warning against use in dementia-related psychosis, increased risk of movement disorders (like tardive dyskinesia), dizziness, falls, and metabolic changes such as weight gain, elevated blood sugar, and higher cholesterol.

Clinicians typically start with a low dose and titrate slowly, monitoring weight, glucose, cholesterol, and blood pressure, while reviewing other medications for interactions. Because Vraylar has a long half-life, side effects may appear or persist for weeks. Never stop it abruptly, and seek urgent care for severe confusion, high fever with muscle stiffness, fainting, or suicidal thoughts.

Because symptoms in older adults—confusion, mood shifts, movement changes—can overlap with many other conditions, it's worth clarifying what you're actually experiencing before your next appointment. A free, instant, online symptom check from Ubie Health can help you identify possible causes, flag red flags, and prepare focused questions for your clinician—so you make the most of your visit and navigate next steps with confidence.

Reviewed for medical accuracy: 07/10/2026

answer background

Explanation

Vraylar Over 65: Navigating Mental Health in Seniors

Mental health conditions such as depression, bipolar disorder, and schizophrenia do not disappear with age. In fact, they can become more complex in later life due to physical health changes, medications, and life transitions. One medication that may be discussed in this context is Vraylar (cariprazine). If you or a loved one is over 65 and considering or already taking Vraylar, understanding how it works and what to watch for is essential.

This article explains Vraylar in clear, everyday language, with a focus on safety, effectiveness, and special considerations for older adults. The goal is to inform without causing unnecessary worry—while still being honest about important risks.


What Is Vraylar?

Vraylar is a prescription antipsychotic medication. It is approved to treat:

  • Schizophrenia
  • Bipolar I disorder, including:
    • Manic or mixed episodes
    • Depressive episodes (bipolar depression)
  • Major depressive disorder (MDD) as an add-on treatment when antidepressants alone are not enough

Vraylar works by affecting certain brain chemicals, mainly dopamine and serotonin, which play key roles in mood, thinking, and behavior.


Is Vraylar Used in People Over 65?

Yes, Vraylar may be prescribed to adults over 65, but it requires careful consideration. Older adults often respond differently to medications than younger people due to:

  • Slower metabolism
  • Changes in kidney and liver function
  • Increased sensitivity to side effects
  • Use of multiple medications (polypharmacy)

Clinical studies of Vraylar included adults, but like many psychiatric medications, there is less data specifically focused on seniors. This does not mean it cannot be used—it means doctors must individualize treatment and monitor closely.


Why Might a Doctor Prescribe Vraylar to a Senior?

A healthcare provider may consider Vraylar for an older adult if:

  • Symptoms of bipolar disorder or schizophrenia are significantly affecting daily life
  • Depression has not improved with standard antidepressants
  • Other medications caused unacceptable side effects
  • The potential benefits outweigh the risks

Mental health conditions can be serious at any age. Untreated or poorly treated illness can increase the risk of hospitalization, functional decline, and reduced quality of life.


Important Safety Considerations for Seniors

1. Black Box Warning: Dementia-Related Psychosis

Like all antipsychotic medications, Vraylar carries a boxed warning for older adults with dementia-related psychosis. Studies have shown an increased risk of death in this group, mostly due to heart-related events or infections.

  • Vraylar is not approved for treating psychosis related to dementia.
  • If a senior has memory loss or dementia symptoms, this must be clearly discussed with a doctor before starting Vraylar.

2. Movement-Related Side Effects

Older adults may be more sensitive to movement symptoms, including:

  • Restlessness (akathisia)
  • Tremors or stiffness
  • Slowed movements

These effects can increase the risk of falls, which is a major concern in seniors.

3. Metabolic and Physical Effects

Vraylar may affect:

  • Weight
  • Blood sugar levels
  • Cholesterol

While Vraylar tends to cause less weight gain than some other antipsychotics, regular monitoring is still important, especially in seniors with diabetes or heart disease.


Common Side Effects of Vraylar

Not everyone experiences side effects, but those reported more often include:

  • Restlessness or feeling unable to sit still
  • Sleepiness or trouble sleeping
  • Nausea or constipation
  • Dizziness, especially when standing up quickly

In adults over 65, dizziness and blood pressure changes can be more significant and may contribute to falls. Any new or worsening symptoms should be reported promptly.


Dosing and Monitoring in Older Adults

Doctors usually follow a "start low and go slow" approach with seniors:

  • Lower starting doses
  • Gradual increases if needed
  • Longer observation periods between dose changes

Monitoring may include:

  • Regular mental health check-ins
  • Blood tests (glucose, cholesterol)
  • Weight and blood pressure checks
  • Review of all other medications to avoid interactions

Because Vraylar stays in the body for a long time, side effects may appear days or even weeks after a dose change.


Mental Health Symptoms Should Not Be Ignored

Depression, mood changes, and unusual behavior are sometimes mistaken as "just part of aging." They are not. If you or a loved one is experiencing:

  • Ongoing sadness or hopelessness
  • Loss of interest in activities
  • Changes in sleep or appetite
  • Confusion or unusual thoughts

It's important to take action. A free, AI-powered Depression symptom checker can help you better understand what you may be experiencing and provide valuable insights to share with your healthcare provider during your next appointment.


Balancing Benefits and Risks

For some seniors, Vraylar can improve mood stability, reduce severe symptoms, and support better daily functioning. For others, the risks may outweigh the benefits. There is no one-size-fits-all answer.

Key questions to discuss with a doctor include:

  • What symptoms are we trying to treat?
  • Are there safer alternatives?
  • How will side effects be monitored?
  • What signs should prompt an urgent call or visit?

When to Seek Immediate Medical Help

While most side effects are manageable, seek medical care right away if any of the following occur:

  • Sudden confusion or severe drowsiness
  • High fever, muscle stiffness, or sweating
  • Fainting or repeated falls
  • Thoughts of self-harm or harm to others

These can be serious or life-threatening and should not wait.


The Importance of Speaking to a Doctor

If you are over 65 and considering Vraylar—or already taking it—speak to a doctor about any concerns, especially if symptoms feel severe, sudden, or frightening. Never stop or change the dose of Vraylar on your own, as this can cause symptoms to worsen.

A healthcare provider can help weigh the risks and benefits, adjust treatment if needed, and ensure that mental health care supports both safety and quality of life.


Final Thoughts

Aging brings changes, but mental health treatment remains important and effective when handled carefully. Vraylar may be a helpful option for some seniors, particularly when symptoms are significant and other treatments have not worked. With thoughtful dosing, close monitoring, and open communication with a doctor, many older adults can use Vraylar safely.

The most important step is staying informed, paying attention to changes, and involving a trusted healthcare professional in every decision—especially when life-threatening or serious symptoms are possible.

(References)

  • * D'Souza, L., Alphs, L., Németh, G., Szatmári, L., & Pikalov, A. A. (2019). Safety and Tolerability of Cariprazine in Elderly Patients with Schizophrenia: A Post Hoc Analysis of Pooled Data. *CNS drugs*, *33*(9), 899-911.

  • * D'Souza, L., Pikalov, A. A., Lu, K., Szatmári, L., Németh, G., & Alphs, L. (2021). Efficacy and Safety of Cariprazine in Elderly Patients With Bipolar I Depression: A Post Hoc Analysis of Pooled Data. *Journal of Clinical Psychopharmacology*, *41*(5), 518-525.

  • * Krogmann, A., Szatmári, L., Németh, G., Kiss, B., & Pál, S. (2018). Pharmacokinetics of Cariprazine in Subjects with Mild, Moderate, or Severe Renal Impairment, and in Subjects with Moderate Hepatic Impairment. *Clinical Pharmacokinetics*, *57*(7), 847-858.

  • * Jeste, D. V., & Krystal, J. H. (2018). Antipsychotic Prescribing for Older Adults: An Update. *The American Journal of Psychiatry*, *175*(11), 1083-1090.

  • * Kim, E., Tingle, K. M., & Rusk, J. (2021). Cariprazine in the treatment of schizophrenia and bipolar disorder: A review of efficacy and safety in adult and older adult populations. *Expert Review of Neurotherapeutics*, *21*(10), 1099-1111.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.